![Hussein Sweiti](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : - $ au 31/08/2026
Hussein Sweiti formerly worked at enGene Therapeutics, Inc., as Chief Medical Officer from 2025 to 2026.
Dr. Sweiti received his doctorate degree from Ruprecht-Karls-Universität Heidelberg and graduate degree from Heinrich-Heine-Universität Düsseldorf.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/09/2025 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 14/06/2026 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heinrich-Heine-Universität Düsseldorf
 Heinrich-Heine-Universität Düsseldorf Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
